IL-3-driven T cell-basophil crosstalk enhances antitumor immunity.
Wei J, Mayberry CL, Lv X, Hu F, Khan T, Logan NA, Wilson JJ, Sears JD, Chaussabel D, Chang CH.
Wei J, et al. Among authors: khan t.
Cancer Immunol Res. 2024 May 13. doi: 10.1158/2326-6066.CIR-23-0851. Online ahead of print.
Cancer Immunol Res. 2024.
PMID: 38739030